Maternal‐fetal immunity and recurrent spontaneous abortion
American Journal of Reproductive Immunology · 2024-05 · 91 (5)
DOI: 10.1111/aji.13859 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Reproductive Immunology, online erschienen am 09.05.2024. Verfasst von Yao Yao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Abortion, Habitual. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 114 Literaturangaben. Gefördert von: Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Recurrent Spontaneous Abortion (RSA) is a common pregnancy complication, that has multifactorial causes, and currently, 40%–50% of cases remain unexplained, referred to as Unexplained RSA (URSA). Due to the elusive etiology and mechanisms, clinical management is exceedingly challenging. In recent years, with the progress in reproductive immunology, a growing body of evidence suggests a relationship between URSA and maternal‐fetal immunology, offering hope for the development of tailored treatment strategies. This article provides an immunological perspective on the pathogenesis, diagnosis, and treatment of RSA. On one hand, it comprehensively reviews the immunological mechanisms underlying RSA, including abnormalities in maternal‐fetal interface immune tolerance, maternal‐fetal interface immune cell function, gut microbiota‐mediated immune dysregulation, and vaginal microbiota‐mediated immune anomalies. On the other hand, it presents the diagnosis and existing treatment modalities for RSA. This article offers a clear knowledge framework for understanding RSA from an immunological standpoint. In conclusion, while the “layers of the veil” regarding immunological factors in RSA are gradually being unveiled, our current research may only scratch the surface. In terms of immunological etiology, effective diagnostic tools for RSA are currently lacking, and the efficacy and safety of immunotherapies, primarily based on lymphocyte immunotherapy and intravenous immunoglobulin, remain contentious.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Hangzhou, China.
- School of Pharmacy, Hangzhou Medical College, Hangzhou, China.
- Department of Pharmacy, Hangzhou First People's Hospital, Hangzhou, China.
ORCID-Profile: Yao Yao, Xiaoyu Cai
Förderung
- Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- National Natural Science Foundation of China
- Medical Science and Technology Plan Project of Zhejiang Province
- Project of Zhejiang Pharmaceutical Society Hospital Pharmacy
Zitieren
APA
Yao, Y., Ye, Y., Chen, J., Zhang, M., Cai, X., & Zheng, C. (2024). Maternal‐fetal immunity and recurrent spontaneous abortion. American Journal of Reproductive Immunology, 91(5). https://doi.org/10.1111/aji.13859
Vancouver
Yao Y, Ye Y, Chen J, Zhang M, Cai X, Zheng C. Maternal‐fetal immunity and recurrent spontaneous abortion. American Journal of Reproductive Immunology. 2024;91(5). doi:10.1111/aji.13859
BibTeX
@article{Yao2024,
author = {Yao, Yao and Ye, Yiqing and Chen, Jia and Zhang, Meng and Cai, Xiaoyu and Zheng, Caihong},
title = {Maternal‐fetal immunity and recurrent spontaneous abortion},
journal = {American Journal of Reproductive Immunology},
year = {2024},
volume = {91},
number = {5},
doi = {10.1111/aji.13859}
}
EUVIMED